Xiamen, China

Xianming Deng

This inventor holds 1 USPTO granted patent. Top assignee: Hongyun Biotech Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xianming Deng. Retrieved from https://idiyas.com/inventor/xianming-deng-m8lusfhs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xianming Deng: Innovator in Alkenyl Pyrimidine Compounds

Introduction

Xianming Deng is a notable inventor based in Xiamen, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways.

Latest Patents

One of his key patents is for an alkenyl pyrimidine compound, which includes a preparation method and its applications. This invention is particularly relevant for its EGFR inhibitory activity, which is crucial in the development of drugs aimed at preventing and treating cancer and other diseases mediated by EGFR kinase. The patent highlights the compound's potential as a pharmaceutical composition, showcasing its importance in modern medicine.

Career Highlights

Xianming Deng has established himself as a prominent figure in the biotech industry. He is currently associated with Hongyun Biotech Co., Ltd., where he continues to innovate and contribute to the advancement of medical science. His work is characterized by a commitment to developing effective treatments for serious health conditions.

Collaborations

Throughout his career, Xianming has collaborated with talented individuals such as Wei Huang and Zhenhua Wu. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Xianming Deng's contributions to the field of pharmaceuticals, particularly through his patent on alkenyl pyrimidine compounds, demonstrate his innovative spirit and dedication to improving healthcare. His work continues to pave the way for new treatments in the fight against cancer and other diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…